Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Profound Medical (PROF) Shares Outstanding (2019 - 2026)

Profound Medical has reported Shares Outstanding over the past 7 years, most recently at $36.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 20.82% year-over-year to $36.3 million; the TTM value through Dec 2025 reached $36.3 million, up 20.82%, while the annual FY2025 figure was $36.3 million, 20.82% up from the prior year.
  • Shares Outstanding for Q4 2025 was $36.3 million at Profound Medical, up from $30.2 million in the prior quarter.
  • Over five years, Shares Outstanding peaked at $36.3 million in Q4 2025 and troughed at $20.8 million in Q4 2021.
  • A 5-year average of $27.5 million and a median of $30.0 million in 2024 define the central range for Shares Outstanding.
  • Biggest five-year swings in Shares Outstanding: rose 0.5% in 2022 and later soared 40.57% in 2024.
  • Year by year, Shares Outstanding stood at $20.8 million in 2021, then rose by 0.5% to $20.9 million in 2022, then increased by 2.35% to $21.4 million in 2023, then surged by 40.57% to $30.0 million in 2024, then grew by 20.82% to $36.3 million in 2025.
  • Business Quant data shows Shares Outstanding for PROF at $36.3 million in Q4 2025, $30.2 million in Q3 2025, and $30.1 million in Q2 2025.